Drug-coated balloon angioplasty superior to conventional balloon angioplasty for stenotic arteriovenous fistula lesions: With caution

The key finding of this study is that stenotic peripheral arteriovenous fistulas (AVF) lesions treated with drug-coated balloon angioplasty (DCB) had a significant improvement in the 6-month and 12-month primary patency rates when compared with those lesions treated with conventional balloon angioplasty.1 Treatment of central venous stenosis was also significantly improved with DCB, although this is more controversial because there are no large diameter drug-coated balloons (10-14  mm) that are approved in the United States.
Source: Journal of Vascular Surgery - Category: Surgery Authors: Tags: Invited commentary Source Type: research